• MPM BioVentures 2018 sold 62,714 Entrada Therapeutics common shares in open-market trades on Aug. 24-26, 2026.
• Sales priced at USD 7.34, USD 7.54, USD 7.06; indirect stake fell to 4,318,348 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entrada Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001231919-26-001106), on August 26, 2026, and is solely responsible for the information contained therein.